ICG makes public-to-private CV play in TowerBrook, CD&R de-listing deal
The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.
Kline Hill, Barings partner up again to co-lead single-asset CV for Havis
The deal marks the first continuation vehicle for Guardian Capital Partners.
StepStone backs separate multi-asset deal on back of Gyrus’s single asset
The firm was a participating investor in a single-asset CV for Essential Pharma.
AlpInvest leads €600m GP-led on specialty pharma asset
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
NYC pension systems disclose details of multi-billion sale
The New York City retirement systems confirmed that four of the five NYC pension funds are involved in the large LP-led secondaries transaction.
Ares emerges as buyer on AXA’s LP-led deal
The process involves moving stakes into a new managed fund, Secondaries Investor has learned.
NYCERS explores $1bn-plus LP-led secondaries process
NYCRS, which oversees five pensions including NYCERS, has a secondaries programme in place with long-term targets ranging from 10-20% of its total PE portfolio.
Partners Group to build ‘local clusters of scale’ with Bluesea Hotels M&A
The private markets firm backed a GP-led process involving Spain’s Bluesea, a hospitality platform.
AlpInvest and Coller step up as lead buyers on Advent’s single-asset CV
Advent is seeking to move business management software, payments and commerce-related technologies provider Xplor into a separate vehicle.
Mastercard Foundation buys $764m of illiquid assets from Kodak pension
The Campbell Lutyens-advised sale comes as the Eastman Kodak Company mulls a potential termination of its pension plan.